Literature DB >> 2731970

Effects of immunization with B. macacae on induced periodontitis--preliminary findings.

R Nisengard1, D Blann, L Zelonis, K McHenry, H Reynolds, J Zambon.   

Abstract

This preliminary study examined the effects of immunization with Bacteroides macacae, the monkey equivalent of the human species of B. gingivalis on ligature-induced periodontitis. During a 12 week immunization period, 8 out of the 12 Macacae fasicularis monkeys were immunized weekly with B. macacae washed cells and 4 were sham-immunized with saline. At the same time, all were scaled and pumiced weekly to establish gingival health. Following this period, the mandibular first molars were ligated in 8 out of the 12 monkeys to induce periodontitis. The immunized, ligated experimental group, the ligated, sham-immunized control group, and the immunized, non-ligated control group were then followed for a 6 months ligation period while plaque was allowed to accumulate. Gingival indices, attachment levels, pocket depths, plaque indices, radiographs, serum and crevicular fluid antibodies and subgingival bacteria were assessed. Immunization led to elevated antibody levels to B. macacae while ligation increased plaque, gingival inflammation, and bone loss. Following the 6 month ligation period, B. macacae comprised 1.7% of the cultivable flora in the immunized, non-ligated monkeys, 2.1% in the immunized, ligated monkeys, and 5.6% in the sham-immunized, ligated monkeys. Similar differences between the immunized, ligated and and the sham-immunized, ligated groups were not seen for B. intermedius, nor B. melaninogenicus. These results suggest a heightened humoral response to B. gingivalis reduces subgingival re-colonization by this organism and modulates the course of ligature-induced periodontitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2731970     DOI: 10.3109/08820138909112239

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  8 in total

1.  Inhibition of pre-existing natural periodontitis in non-human primates by a locally administered peptide inhibitor of complement C3.

Authors:  Tomoki Maekawa; Ruel A Briones; Ranillo R G Resuello; Joel V Tuplano; Evlambia Hajishengallis; Tetsuhiro Kajikawa; Sophia Koutsogiannaki; Cristina A G Garcia; Daniel Ricklin; John D Lambris; George Hajishengallis
Journal:  J Clin Periodontol       Date:  2016-03-03       Impact factor: 8.728

2.  Prevaccination with SRL172 (heat-killed Mycobacterium vaccae) inhibits experimental periodontal disease in Wistar rats.

Authors:  T Breivik; G A Rook
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

3.  Functional properties of nonhuman primate antibody to Porphyromonas gingivalis.

Authors:  D M Anderson; J L Ebersole; M J Novak
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

4.  Virulence of Wolinella recta in a murine abscess model.

Authors:  L Kesavalu; S C Holt; R R Crawley; R Borinski; J L Ebersole
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

5.  Effects of immunization with Porphyromonas gingivalis and Prevotella intermedia on progression of ligature-induced periodontitis in the nonhuman primate Macaca fascicularis.

Authors:  J L Ebersole; M Brunsvold; B Steffensen; R Wood; S C Holt
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

6.  Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components.

Authors:  L Kesavalu; J L Ebersole; R L Machen; S C Holt
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

7.  Serum immunoglobulin G antibody to Porphyromonas gingivalis in rapidly progressive periodontitis: titer, avidity, and subclass distribution.

Authors:  C Whitney; J Ant; B Moncla; B Johnson; R C Page; D Engel
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

8.  Influence of immunization on Porphyromonas gingivalis colonization and invasion in the mouse chamber model.

Authors:  C A Genco; D R Kapczynski; C W Cutler; R J Arko; R R Arnold
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.